High out-of-pocket costs lead patients to skip medications. Financial assistance programs improve adherence, but complex insurance strategies may hinder access.
Brianna Champagne, BSPharm
Advertisement
Articles by Brianna Champagne, BSPharm
Long-term benzodiazepine use has been linked to lasting cognitive impairments, underscoring the vital role pharmacists play in supporting safe deprescribing strategies.
Hallucinatory affects associated with psychedelic drugs and Lewy body diseases may have some commonalities.
Advertisement
Latest Updated Articles
Financial Assistance vs Co-pay Accumulators: Protecting Patients From Cost ShockPublished: January 16th 2026 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5